These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5526751)

  • 1. The pathology of experimental infection of cattle with Fasciola gigantica.
    Bitakaramire PK; Bwangamoi O
    Bull Epizoot Dis Afr; 1970 Jun; 18(2):149-57. PubMed ID: 5526751
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic changes in natural Fasciola gigantica infestations of the Fulani Zebu.
    Uzoukwu M; Ikeme MM
    Bull Anim Health Prod Afr; 1978 Jun; 26(2):162-7. PubMed ID: 749966
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthelmintic effect of rafoxanide against immature Fasciola hepatica in calves.
    Presidente PJ; Knapp SE
    Am J Vet Res; 1972 Aug; 33(8):1603-10. PubMed ID: 5047119
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of an acquired resistance in calves to a single experimental infection with Fasciola hepatica.
    Doyle JJ
    Res Vet Sci; 1972 Sep; 13(5):456-9. PubMed ID: 4635117
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between the duration of a primary infection and the subsequent development of an acquired resistance to experimental infections with Fasciola hepatica in calves.
    Doyle JJ
    Res Vet Sci; 1973 Jan; 14(1):97-103. PubMed ID: 4707901
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials with rafoxanide. 2. Efficacy against Fasciola gigantica in cattle.
    Snijders AJ; Horak IG; Louw JP
    J S Afr Vet Med Assoc; 1971 Sep; 42(3):253-7. PubMed ID: 5161408
    [No Abstract]   [Full Text] [Related]  

  • 8. The pathogenic effect of experimental infections with Fasciola gigantica in cattle.
    Hammond JA; Sewell MM
    Br Vet J; 1974; 130(5):453-65. PubMed ID: 4434159
    [No Abstract]   [Full Text] [Related]  

  • 9. Early migration of immature Fasciola hepatica and associated liver pathology in cattle.
    Doy TG; Hughes DL
    Res Vet Sci; 1984 Sep; 37(2):219-22. PubMed ID: 6505402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia.
    Molloy JB; Anderson GR; Fletcher TI; Landmann J; Knight BC
    Vet Parasitol; 2005 Jun; 130(3-4):207-12. PubMed ID: 15925723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran.
    Ashrafi K; Valero MA; Panova M; Periago MV; Massoud J; Mas-Coma S
    Parasitol Int; 2006 Dec; 55(4):249-60. PubMed ID: 16901748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the pathology of bovine and murine liver infected with Fasciola hepatica with reference to the mast cell and globule leucocyte.
    Rahko T
    Ann Acad Sci Fenn A; 1971; 148():1-62. PubMed ID: 5153579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Emergence in humans of fascioliasis (from Fasciola gigantica) and intestinal distomatosis (from Fasciolopsis buski) in Laos].
    Quang TD; Duong TH; Richard-Lenoble D; Odermatt P; Khammanivong K
    Sante; 2008; 18(3):119-24. PubMed ID: 19359231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological studies of Fasciola gigantica infections in cattle in the highveld and lowveld communal grazing areas of Zimbabwe.
    Pfukenyi DM; Mukaratirwa S; Willingham AL; Monrad J
    Onderstepoort J Vet Res; 2006 Mar; 73(1):37-51. PubMed ID: 16715877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical demonstration of glycogen and fat in normal and fasciola infected liver of cattle.
    Ramadan AA; Khadre SE
    Folia Morphol (Praha); 1982; 30(3):322-8. PubMed ID: 7141347
    [No Abstract]   [Full Text] [Related]  

  • 16. First phenotypic description of Fasciola hepatica/Fasciola gigantica intermediate forms from the human endemic area of the Nile Delta, Egypt.
    Periago MV; Valero MA; El Sayed M; Ashrafi K; El Wakeel A; Mohamed MY; Desquesnes M; Curtale F; Mas-Coma S
    Infect Genet Evol; 2008 Jan; 8(1):51-8. PubMed ID: 18006385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interferon-gamma and interleukins-6 and -8 during infection with Fasciola gigantica in cattle and buffaloes.
    Molina EC
    J Vet Sci; 2005 Jun; 6(2):135-9. PubMed ID: 15933433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fascioliasis and the presence of hybrid/introgressed forms of Fasciola hepatica and Fasciola gigantica in Vietnam.
    Le TH; De NV; Agatsuma T; Thi Nguyen TG; Nguyen QD; McManus DP; Blair D
    Int J Parasitol; 2008 May; 38(6):725-30. PubMed ID: 18031748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress in concomitant occurrence of Fasciola gigantica and leiomyoma in cattle.
    Bahrami S; Esmaeilzadeh S; Oryan A
    Vet Parasitol; 2014 Jun; 203(1-2):43-50. PubMed ID: 24636711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine fascioliasis in Nigeria. V. The pathogenicity of experimental infections in White Fulani cattle.
    Ogunrinade AF
    Rev Elev Med Vet Pays Trop; 1983; 36(2):141-9. PubMed ID: 6665268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.